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Postnatal DNA demethylation and its role in
tissue maturation
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Klaus Rajewsky6, Klaus H. Kaestner2 & Howard Cedar 1
Development in mammals is accompanied by specific de novo and demethylation events that
are thought to stabilize differentiated cell phenotypes. We demonstrate that a large per-
centage of the tissue-specific methylation pattern is generated postnatally. Demethylation in
the liver is observed in thousands of enhancer-like sequences associated with genes that
undergo activation during the first few weeks of life. Using a conditional gene ablation
strategy we show that the removal of these methyl groups is stable and necessary for
assuring proper hepatocyte gene expression and function through its effect on chromatin
accessibility. These postnatal changes in methylation come about through exposure to
hormone signaling. These results define the molecular rules of 5-methyl-cytosine regulation
as an epigenetic mechanism underlying cellular responses to a changing environment.
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DNA methylation patterns are established during mam-malian embryogenesis through a programmed processthat involves both de novo and demethylation events.
Initially, most methyl groups are erased in the early embryo
before a new bimodal pattern is established at the time of
implantation, where almost all CpG sites undergo de novo
methylation while CpG islands are protected by virtue of cis-
acting regulatory sequences1. Following implantation, all sub-
sequent changes in DNA methylation appear to be gene specific,
with pluripotency genes, for example, becoming de novo
methylated at the time of gastrulation2,3, while tissue-specific
regulatory regions undergo demethylation during embryonic
development4,5 or during adult stem cell differentiation6. These
processes are triggered by external signaling factors, which then
direct interactions between cis-acting sequences and trans-acting
proteins within the cell that have the ability to recruit either the
de novo methylation complex or demethylation machinery1.
Once the epigenetic alterations occur, they serve to autonomously
maintain these developmental decisions by generating a stable
chromatin template that can persist for long time periods1.
It is generally believed that the DNA methylation patterns
established during development do not undergo further altera-
tions, but recent studies indicate that methylation changes may
indeed occur postnatally in terminally differentiated tissues. This
has been observed, for example, in cardiomyocytes where many
gene regions become hypomethylated or hypermethylated during
heart muscle maturation7 and stable programmed demethylation
of defined regulatory sites also occurs postnatally in the mam-
mary tissue following pregnancy8 as well as in the liver9,10, where
some of these events are mediated by the secretion of testoster-
one11. It has been suggested that DNA methylation changes may
also be induced by the environment or by specific behaviors12. In
this paper, we have used high-throughput analysis to demonstrate
the existence of programmed postnatal changes in methylation in
many different tissues of the body. Furthermore, using the liver as
a model system, we show that these changes, which are induced
by hormone signaling, are associated with extensive alterations in
gene expression that take place during the first few weeks after
birth. Finally, by employing genetic intervention, we show that
these methylation changes play a role in the process.
Results
Postnatal demethylation. In order to investigate the possibility
that methylation patterns are subject to postnatal alterations, we
analyzed genome-wide methylation in the mouse liver from the
time of birth through adult life. This was accomplished using
reduced representation bisulfite sequencing (RRBS), a technique
that covers a large fraction of the regulatory sequences present in
DNA and at sufficient depth to obtain reproducible results13. By
choosing strict criteria to characterize DNA methylation changes
(see Methods), we found over 9000 tiles (100 bp) that are
undermethylated (>50% reduction) specifically in the adult
liver as compared to DNA from a panel of other cell types
(p value <10−4, permutation test). While most of these sites are
already unmethylated in 5-day-old liver (1 week), about 2800
actually undergo significant demethylation (>35%) postnatally,
with a large number of these (~1800) losing their methyl groups
only after 3 weeks (Fig. 1a). Unbiased clustering analysis of the
entire RRBS data set showed that these differentially methylated
regions (DMRs) are highly reproducible and statistically robust
(Fig. 1b). Interestingly, even though many regions undergo spe-
cific de novo methylation in the liver, only a small number of
these sites (~10%) become modified postnatally (Supplementary
Fig. 1a). Of note, all of these measurements were carried out on
purified hepatocytes, thus verifying that this process is truly cell
autonomous and not the result of changes in cell composition
during maturation of the liver.
Biochemical mechanism of demethylation. Demethylation
during early stages of embryogenesis is mediated by combinations
of TET enzymes which hydroxylate 5mC14–19, thus setting the
stage for replacement either through replication dilution or active
DNA repair processes20–23. This also seems to be the case for the
postnatal demethylation observed in the liver, as indicated by
whole-genome analysis (see Methods), demonstrating that these
DMRs are highly enriched for 5hmC (Supplementary Fig. 2).
Recently, it was demonstrated that the specific combination of
TET2 and TET3 is necessary for the demethylation that takes
place during B cell development in vivo24. In order to test whe-
ther postnatal demethylation in the liver is also accomplished in
this manner, we first verified that both Tet2 and Tet3, but not
Tet1, are expressed in hepatocytes. Tet2F/Tet3F mice25,26 were
then injected either at 1 day or 3 weeks after birth with adeno-
associated virus 8 (AAV8) carrying the gene for Cre recombinase
under the control of the hepatocyte-specific thyroid-binding
globulin (Tbg) promoter27 and followed until they reached the
age of 15 weeks. Preliminary control experiments indicated that
infection with AAV in this manner works efficiently to delete
target sequences (Supplementary Fig. 3).
Using both RRBS (Fig. 1) and whole-genome bisulfite
sequencing (WGBS) (Supplementary Fig. 2), we then analyzed
all the sites that normally undergo demethylation in the liver.
Double mutants (DKO) of Tet2/Tet3 at birth completely
prevented subsequent demethylation. Notably, while some of
the regions begin to undergo demethylation immediately after
birth, almost half of them are demethylated much later, after the
first three weeks of life. Removal of Tet2 and Tet3 by infection
with AAV8-cre at 3 weeks was able to inhibit demethylation at
these sites, but regions that had already undergone demethylation
prior to AAV8-cre administration remained largely hypomethy-
lated in these animals (<6% increase). Similar results were
obtained when gene ablation was carried out in older animals
(15 weeks) following completion of all demethylation events
(Fig. 1). This is consistent with the notion that once established,
the unmethylated state is autonomously maintained without the
need for continuous demethylase activity28. Taken together, these
results show that postnatal demethylation in the liver is mediated
by TET2/TET3 and that in the absence of these enzymes the
methylation pattern in hepatocytes remains invariant (Fig. 1). It
should be noted that the double mutant had no effect on
postnatal de novo methylation (Supplementary Fig. 1a).
To gain insight into the nature of DNA segments that undergo
postnatal demethylation in the liver, it was necessary to generate a
more comprehensive picture of this phenomenon, and to this
end, we carried out WGBS analysis on a limited number of
hepatocyte samples. This experiment, which was done at a
sequencing depth (>30-fold) that allowed the accumulation of
highly significant data, revealed approximately 52,000 regions
that undergo demethylation postnatally (Supplementary Dataset 1
and Supplementary Fig. 2) with an average size of about 250 bp
(Supplementary Fig. 2c). These regions are distributed within a
distinct window around its nearest transcription state site (TSS),
including both intragenic and intergenic regions of the genome,
with very few (<2%) located in promoter regions themselves
(Supplementary Fig. 2d, e). Analysis of published chromatin
immunoprecipitation-sequencing (ChIP-Seq) data indicated that
these regions are highly enriched for histone H3K4me1 and
H3K27ac in the adult liver, but not in other tissues or liver from
newborn animals (Fig. 2a).
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Enhancer demethylation mediates gene expression. This finding
suggests that these sequences may represent enhancer elements
that become activated postnatally and bioinformatics analysis
shows that they are indeed enriched for a number of different
common enhancer-binding motifs (genomatix genome analyzer,
https://mygga.genomatix.de/) of transcription factor families
known to be important in hepatocytes (Fig. 2b). Indeed, many of
these sites have a DNaseI-sensitive conformation indicative of
protein binding, and several of these factors bind to their
demethylated target sequences in the adult liver (Fig. 2c). This
suggests that postnatal demethylation occurs at regulatory sites
and Gene Ontology (GO) analysis indicates that these sequences
are located near genes that are highly enriched for various aspects
of liver function (Fig. 2d). Indeed, over 4500 of these DMRs
actually represent elements within previously identified hepato-
cyte super-enhancers29.
In order to test whether changes in methylation that occur
postnatally may also have an effect on gene expression, we carried
out RNA-Seq analysis on hepatocyte samples from newborn,
3-week-old and 15-week-old animals. Under the assumption that
the DMRs detected in the liver are enhancer-like regulatory
sequences, we first analyzed the ~31,000 sites that are located
within or adjacent to known genes (see Methods and Supple-
mentary Fig. 4). About 30% of these regions (n= 8500) are
associated with genes (n= 1212) that show a significant (p value
<10−27, z-score of proportions) postnatal increase in mRNA
levels (Fig. 3a). This represents over 60% of all genes (n= 2070)
that are upregulated during liver maturation between 1 and
15 weeks. Moreover, this increase in transcription was signifi-
cantly inhibited in Tet2/Tet3 double mutant animals (Fig. 3b and
Supplementary Fig. 5).
As a control, we examined mice that underwent gene ablation
at 15 weeks, well after completion of all demethylation events and
found that removal of Tet2/Tet3 had almost no effect on the
transcription of these genes. This clearly indicates that it is
demethylation at these enhancer sequences itself that plays a
direct role in gene induction. We next examined the effects of
deleting Tet2/Tet3 at 3 weeks. As expected, DMRs that undergo
demethylation after this point are associated with genes whose
expression begins to increase after 3 weeks, and these are
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Fig. 1 Postnatal demethylation in the liver. a Heatmap of specifically undermethylated 100 bp regions (n= 9000) measured in hepatocytes from WT or
Tet2F/Tet3F (*) animals at different ages and in other tissues (lung, heart, neutrophils, brain, fat) by RRBS. Animals were injected with AAV8-expressing
Cre under the Tbg-Cre promoter at 1 day, 3 weeks, or 15 weeks (control or DKO). Note that there is only a slight degree of remethylation (<6%) in the
3-week DKO samples. Hepatocytes were also isolated from newborn mice and cultured in vitro for 3 weeks. b Unbiased hierarchical clustering analysis on
the entire hepatocyte RRBS data set without selection for specific sequences, including the injection controls and in vitro grown hepatocytes (1 week).
Injected control samples are included in the 12–15 weeks group
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substantially affected by loss of the TET enzymes (Fig. 3c). In
contrast, the expression of genes containing DMRs that have
already undergone demethylation prior to 3 weeks was largely
unaffected by the late gene deletion (Fig. 3d), again supporting
the idea that the main effect of TET2/TET3 is at the level of
demethylation.
It should be noted that about 70% of the intragenic DMRs
(n= 22,659) are associated with genes that do not undergo
significant postnatal induction (Supplementary Fig. 4). None-
theless, these sites, as well as the intergenic DMRs (n= 21,023),
appear to be packaged into nucleosomes containing the enhancer
marks H3K4me1 and H3K27ac, are sensitive to DNaseI, and bind
liver-specific transcription factors to the same extent as those
located within the genes that do undergo postnatal transcriptional
activation (Fig. 2 and Supplementary Fig. 4), suggesting that these
DMRs may also be involved in gene activation. In order to test
this possibility, we took advantage of chromosome conformation
capture (Hi-C)30 data obtained from liver cells, and in this way,
physically identified additional interactions between DMRs and
postnatally induced genes. Taken together, these data indicate
that the DMRs identified in this study interact with and may
influence a relatively large percentage of all postnatally induced
genes.
Functional mechanism of demethylation. Since demethylation
appears to be important for achieving proper levels of gene
expression, we next took advantage of our Tet2/Tet3-deficient
mice to ask whether this mechanism operates by affecting gene
structure. To this end, we carried out an assay for transposase-
accessible chromatin with high-throughput sequencing (ATAC-
Seq) on both wild-type (WT) and Tet2/Tet3-deficient (1 day)
adult hepatocytes and specifically examined the postnatal DMR
regions. Strikingly, while many DMRs were detected in this assay,
these same exact sites were found to be locally inaccessible in the
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Fig. 2 Characterization of regions that undergo postnatal demethylation in hepatocytes. a ChIP-Seq of demethylated regions (52,000 200 bp tiles as
determined by WGBS) as a function of distance from their center for H3K4me1 and H3K27ac in adult liver (blue), newborn liver (red), and other tissues
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mutants (Fig. 4a and Supplementary Fig. 6). This is in contrast to
prenatally formed DMRs that are unaffected by Tet2/Tet3 defi-
ciency and therefore serve as a negative control. In addition,
ChIP-Seq analysis shows that binding of the liver-enriched
transcription factor HNF6 is also reduced in the presence of DNA
methylation (Fig. 4b and Supplementary Fig. 6). Although it has
been previously demonstrated that DNA methylation affects
chromatin structure31,32, our experiments represent the first
definitive proof of this principle in vivo. It should be noted that
DNA methylation only had a very minor influence on the pre-
sence of histone markers H3K4me1 and H3K27ac, as shown by
ChIP-Seq analysis, probably because these modifications tend to
have a regional pattern that may not be significantly affected by
local changes in DNA methylation (Supplementary Fig. 7).
Phenotype of Tet DKO. Considering the extensive changes in
methylation and transcription that are seen in the Tet2/Tet3
double mutant, we next asked whether these molecular indicators
are also reflected in liver function (Fig. 5). In all of the 1 day
mutant mice, both males and females, we observed an increased
liver mass to body weight ratio of about 60% compared to control
mice (Fig. 5a, b) and histological analysis indicated that this may
be due to increased cell size as measured quantitatively by
E-cadherin staining (Fig. 5c, d). We also carried out blood bio-
chemistry in order to determine whether the lack of demethyla-
tion brings about metabolic changes. This revealed that while
most biochemical indicators of liver function are not altered in
the Tet2/Tet3-deficient animals, there were significant increases
in blood glucose, cholesterol, and high-density lipoprotein (HDL)
in all male mutant mice, but not in females, whether the gene
ablation was induced early (1 week) or late (3 weeks). This sug-
gests that the effect on metabolism may come about because of a
lack of male-specific testosterone-mediated late demethylation
(after 3 weeks)11, as confirmed by showing that these biochemical
changes do not occur in castrated mice (Fig. 5e). In keeping with
this, bioinformatic analysis indicated that a number of genes
associated with male-specific DMRs are indeed functionally
involved in glucose (e.g., Fto, Insr, Gpd2, Gsk3b) and lipid
(e.g., Lpin1, Scp2, Cyp7b1, Fabp6) metabolism possibly explaining
the DKO phenotype (Supplementary Fig. 8).
Demethylation is mediated by insulin signaling. Initial studies
indicated that newborn hepatocytes cultured for several weeks
in vitro still maintain the same methylation pattern as that seen in
1-week-old animals (Fig. 1). This suggested that the postnatal
alterations we observed are not an intrinsic part of the hepatocyte
methylation program, but rather depend on factors found in vivo
that are evidently not present in the culture medium. Indeed,
many different factors and hormones are known to influence
neonatal development, with insulin playing a central role in this
process33. To test whether this hormone may play a role in
hepatic postnatal demethylation, we took advantage of the
existing InsRF/F mouse34 and injected it right after birth with
AAV8 Tbg-Cre. These animals, which are defective for the InsR
specifically in hepatocytes, were analyzed by RRBS and compared
to WT animals at 15–20 weeks. Strikingly, about 40% of the
normal DMRs remained highly methylated in the mutant hepa-
tocytes (Fig. 6), clearly indicating that insulin signaling is neces-
sary, directly or indirectly, for a major portion of the methylation
changes that occur postnatally. It should be noted that the InsR
ablation affected almost exclusively DMRs that are formed after
3 weeks. This is consistent with the observation that other
insulin-signaling-dependent effects occur at this stage35, perhaps
because of the change in insulin levels that take place during the
first two weeks of life36.
Postnatal demethylation in other tissues. We next asked whe-
ther postnatal demethylation represents a general phenomenon.
To this end, we used RRBS to identify cell-type-specific deme-
thylation in other tissues, including lung, heart muscle, and
hippocampus, and then compared methylation levels in newborn
(1 week) and adult (15 weeks) samples. As in the liver, we
observed considerable developmentally generated under-
methylation in each tissue, but in addition, identified many sites
that undergo demethylation postnatally (Fig. 7). In all of these cell
types, the DMRs are enriched for H3K4me1 and H3K27ac, but
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Fig. 4 Effect of DNA methylation on chromatin accessibility. a ATAC-Seq of postnatal DMRs (2800 100 bp regions as determined by RRBS) as a function
of distance from their center in WT (blue) and DKO (red) adult (15 weeks) hepatocytes. Also shown for comparison (lower panel) is an analysis of
hepatocyte-specific prenatal DMRs that are already fully unmethylated (<5%) in 1 week hepatocytes (n= 1290). b ChIP-Seq of postnatal and prenatal
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only in their undermethylated state, suggesting that many of these
regions represent enhancer-like regulatory elements that get
activated during the first few weeks of life (Supplementary Fig. 9).
Published RNA-Seq analysis (see Methods) confirmed this idea
by demonstrating that many of these tiles are associated with
genes that are indeed upregulated postnatally. These findings are
consistent with a previous report on demethylation in β-cells37.
Discussion
During development, individual cell types are generated through
a serial process of differentiation characterized by programmed
changes in gene expression that give each tissue its specific
qualities and functions. In mammals, this is accomplished in
parallel with alterations in DNA methylation that serve to sta-
bilize the differentiated state1. Recent studies have indicated that
most of these DMRs correspond to enhancer-like sequences4,5,38
that often act as regulatory elements for nearby genes. It has been
assumed that these changes take place exclusively during tissue
formation in the embryo, yielding mature cell types that then
continue functioning with the same stable methylation pattern for
the lifetime of the organism. Here we demonstrate that many
tissues continue to shape their epigenetic landscape after birth,
suggesting that each cell type may undergo post-developmental
molding even after the main process of tissue differentiation has
terminated.
On the basis of previous studies demonstrating that deme-
thylation is usually carried out through a TET-mediated 5hmC
intermediate39, we generated a conditional Tet2/Tet3 double
mutant that completely inhibited the biochemical removal of
methyl groups from their programmed regulatory sites in vivo,
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NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04456-6 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2040 | DOI: 10.1038/s41467-018-04456-6 |www.nature.com/naturecommunications 7
thus enabling us to directly test the role of demethylation in the
regulation of hepatocyte gene expression. Our studies indicate
that in the absence of demethylation, many genes are inhibited in
their ability to undergo induced expression postnatally and this is
observed to a large extent precisely at those genes that contain
DMRs, indicating a direct effect. We have also carried out
important control experiments showing that the TET proteins
themselves have no influence on target gene transcription once
they are already demethylated (Fig. 3). Taken together, these data
suggest that demethylation per se is required for generating a
proper postnatal gene transcription program. While for some
genes this demethylation brings about a relatively large change in
RNA levels (Supplementary Fig. 4), its overall role on gene
expression in the postnatal liver appears to be more as a fine-
tuning mechanism. Nonetheless, these epigenetic events clearly
regulate important aspects of liver size and function (Fig. 5).
Previous experiments using reverse epigenetics had already
demonstrated that the presence of methyl groups at regulatory
sequences serves as an inhibitor of gene expression in vivo40,41,
but it was not clear how methylation works dynamically in
turning on and turning off transcription. It has been demon-
strated, for example, that de novo methylation itself does not act
as a primary mechanism for repression, but rather takes place
after transcription has already been turned off, thus serving as a
secondary locking device to prevent gene activation at subsequent
stages of development2,3. A corollary to this concept is that the
removal of methylation must be required to turn on transcription.
Support for this idea initially came from studies in differentiated
ES cells42 and was then proved in vivo by genetically preventing
demethylation during B cell-lineage differentiation24 and during
intestinal stem cell renewal43. Our experiments with the Tet2/
Tet3 mutants clearly confirm this general principle and lay to rest
any doubts44 about the role of DNA methylation as an inhibitor
of gene expression.
The overall impression from these results is that the liver
undergoes programmed postnatal changes in gene expression that
are initially mediated by trans-acting factors, but then become
fixed into the fabric of chromatin much in the same manner that
developmental changes in methylation during embryogenesis are
retained as an epigenetic memory in the adult. It is very likely that
these events occur in response to behavioral or internal envir-
onmental changes that take place after birth. We have indeed
demonstrated that a significant part of this process is mediated by
insulin signaling in the liver. Physiologically, these postnatal
alterations are probably triggered by the metabolic transition
from a maternal source of energy to the initiation of nursing right
after birth and then again by the weaning process 3 weeks later. In
keeping with this, many of the demethylation events actually
occur in genes involved in energy metabolism (Fig. 2).
The picture that emerges from these studies is that postnatal
demethylation can be mediated by hormones and other metabolic
signals which affect the expression or activity of key
tissue-specific pioneer factors that recognize the gene regulatory
regions and facilitate recruitment of the demethylation machinery
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Fig. 6 Effect of insulin receptor ablation on postnatal demethylation. a Methylation heatmap (RRBS) showing 2800 DMRs from WT and InsR-deficient
(1 day) hepatocytes that undergo demethylation postnatally from 1 week to 15 weeks. Note that InsR ablation affects mainly those sites (n= 1520) that
undergo demethylation after 3 weeks (marked with blue bar). b Box plot of methylation levels for these 1520 DMRs
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Fig. 7 Postnatal demethylation in various tissues. Methylation heatmap
(RRBS) of hepatocyte-specific (n= 9408), heart-specific (n= 892),
lung-specific (n= 914), and hippocampus-specific (n= 3630) DMRs
(p value <10−4, permutation test) ranked according to newborn
methylation levels in each tissue
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(Tet2/Tet3). Our experiments (ATAC-Seq) indicate that removal
of methyl groups brings about a local increase in accessibility that
promotes additional transcription factor-binding in vivo. Indeed,
it is likely that while tissue-specific factors may be responsible for
priming these regulatory sequences, demethylation could serve to
open them further in order to allow the binding of additional
transcription factors. In keeping with this hypothesis, an analysis
of data obtained from the human ENCODE project indicates that
a variety of different general factors bind exclusively to DMRs in
each specific cell type, even though there are many other
methylated enhancer-like binding sites present in the same cell
(Supplementary Fig. 10).
In light of the extensive postnatal methylation changes that
take place in different cell types throughout the body, it is
tempting to suggest that similar alterations could take place as a
result of exposure to environmental influences such as diet,
physical activity, pharmacological intervention, disease, or
trauma. If this were the case, our results suggest that this might
occur through the induction of hormones and other signaling
molecules that would then interact with cells, thus signaling a
programmed process of changes that brings about a specific
pattern of demethylation. Although the trigger for these events
might be transient, the concomitant change in DNA methylation
may alter expression patterns in a stable manner that can be
“remembered” epigenetically even after the original “inducers”
are no longer present in these cells11.
Methods
Animals and cells. C57Bl mice were used for all experiments. DKO mice were
generated from Tet2F/Tet3F mice26,45. A total of 2 × 1011 genome copies of AAV8
carrying the gene for Cre under the hepatocyte-specific Tbg promoter (Penn
vector) were injected into the superficial temporal vein of 1-day-old mice following
anesthetization on ice. Three-week-old mice were anesthetized and injected in the
jugular vein with 1012 genome copies of this same virus. Liver-specific insulin
receptor knockout mice were generated in a similar manner using InsRF mice34. All
animal experiments were performed in accordance with the guidelines of the
Hebrew University Institutional Committee for the Use of Animals for Research.
Mice were anesthetized, sacrificed, and subjected to liver perfusion. Whole liver
was then digested by collagenase (Roche) and hepatocytes removed and isolated by
means of a percoll gradient46. Cells were then stained with a CD-45 antibody
(Biotech) and FACS sorted according to size and to negative staining for CD-45.
This yielded a population of relatively pure (>95%) hepatocytes. Unsorted liver
cells from newborn mice were seeded and grown on collagenase-coated tissue
culture plates containing hepatocyte medium supplemented with 5% fetal bovine
serum, 1% hepatic growth supplement, 100 U/mL penicillin, and 100 µg/mL
streptomycin (ScienCell) for 2–4 weeks.
RRBS and WGBS. DNA was isolated from mouse hepatocytes or from snap-frozen
mouse tissues and incubated in lysis buffer (25 mM Tris-HCl (pH 8), 2 mM
ethylenediaminetetraacetic acid, 0.2% sodium dodecyl sulfate, 200 mM NaCl)
supplemented with 300 μg/mL proteinase K (Roche) followed by phenol:chloro-
form extraction and ethanol precipitation and RRBS libraries were prepared13 and
run on HiSeq 2500 (Illumina) using 100 bp paired-end sequencing. WGBS libraries
were prepared using the Ovation® Ultralow Methyl-Seq Library System (NuGEN
Technologies Inc.) as per the manufacturer’s instructions. One hundred and fifty
nanograms of genomic DNA was sheared with the M220 Focused-ultra-
sonicator™(Covaris®) using the 200 bp snap-cap protocol and subsequently purified
with AMPure XP beads. After end repair, adaptor ligation, and final repair, DNA
was bisulfite converted with the EpiTect Fast DNA Bisulfite Kit (Qiagen GmbH)
following the cycling conditions specified in the Ovation® Ultralow Methyl-Seq
Library System protocol. Libraries were then amplified, purified, pooled, and
sequenced on the Illumina HiSeq with 70 bp paired-end sequencing. Sequencing
was conducted by the University of Pennsylvania Next-Generation Sequencing
Core (Philadelphia, PA, USA) at a depth that exceeds the 30-fold “gold standard”
commonly achieved in WGBS databases.
RNA-Seq, ChIP-Seq and 5hmeDIP-Seq. RNA was isolated from mouse hepato-
cytes using the miRNeasy Kit according to the manufacturer’s instructions (Qia-
gen). RNA-Seq libraries were generated using the TruSeq RNA Sample Preparation
Kit v2 (Illumina). For ChIP analysis, chromatin was fixed and sheared with the
M220 Focused-ultrasonicator™ (Covaris®) using the microTube snap-cap. Five
micrograms of chromatin was then immunoprecipitated with 2 μg of H3K4me1,
H3K27ac (Abcam), or HNF6 (Santa Cruz, sc-13050) antibodies. Libraries were
generated using the NEBNext Ultra™ II DNA Library Prep Kit for Illumina (New
England Biolabs).
The ATAC-Seq protocol47,48 was carried out on WT or Tet2/3 DKO
hepatocytes with the following modifications. Nuclei were washed with 150 μl of
cold phosphate-buffered saline, pelleted at 2000 × g at 4 °C for 5 min, re-suspended
in 150 μl of cold lysis buffer, and then re-pelleted for 2000 × g at 4 °C for 10 min.
Nuclei were re-suspended in 150 μl of transposition reaction mix and incubated at
37 °C for 30 min. DNA was isolated (Qiagen MinElute Reaction Cleanup Kit) and
subjected to PCR amplification to make the library48. Magnetic beads (AMPure
XP) were used to purify an ATAC-Seq library47, followed by quality control with a
high-sensitivity DNA bioanalysis chip (Agilent), quantification with KAPA
(Illumina), and QuBit. The libraries were sequenced (75 bp paired-end) on Next-
Seq (Illumina).
For 5hMeDIP-Seq, DNA was isolated from hepatocytes harvested from a
20-day-old mice and sheared with the M220 Focused-ultrasonicatorTM (Covaris)
using snap-cap tubes. Libraries were generated using the NEBNext Ultra DNA
Library Prep Kit (NEB E7645). Library DNA was denatured in 95 °C for 10 min,
and then the denatured DNA was precipitated with 5hmC Ab (Active Motif 55010)
and sequenced (50 bp single-end) on Next-Seq (Illumina).
Functional analysis. Blood serum was collected by cardiac puncture from
overnight-fasted mice and tested for cholesterol, HDL, and triglyceride levels.
Blood glucose levels from overnight-fasted mice were measured by glucose test
strips (Roche). Liver tissue was fixed in 4% formaldehyde for 8 h and then pre-
served in 70% ethanol. Liver was embedded in paraffin, sliced, and mounted on
slides, which were then stained with an E-Cadherin antibody and Cherry secondary
antibody as well as DAPI (4',6-diamidino-2-phenylindole) (Sigma). Cell size was
calculated using the Image J software.
Data analysis. A chart of all high-throughput experiments is shown in Supple-
mentary Fig. 11. All data have been deposited in the Gene Expression Omnibus
(GEO) under accession number GSE85251. DNA methylation was analyzed by
using 100 bp paired-end sequencing reads from RRBS that were trimmed and
quality filtered by trim galore software (v.0.3.3) using default parameters for RRBS
with the following command:
trim_galore–rrbs–paired sample_R1.fastq.gz sample_R2.fastq.gz
Read alignment (genome build mm9) and extraction of single-base resolution
methylation levels were carried out by BSMAP v.2.74 (Ref. 49) using the following
commands:
bsmap -a sample_R1_val_1.fq.gz -b sample_R2_val_2.fq.gz -d
mm9_AllGenome.fa -o bam_file -R -D C-CGG
python methratio.py -i “no-action” -p -g -z -o sample_trim_galore_mm9.fa.
meth -d mm9_AllGenome.fa bam_file
Percent methylation was calculated for 100 bp tiles with a minimum coverage of
10 CpGs. Hepatocyte-specific undermethylated or de novo methylated regions were
at least 50% less or more methylated in five out of nine different tissues. This
relatively large cutoff was chosen in order to maximize for specificity and
significance. Using these DMRs as our starting material, postnatally demethylated
regions were then defined as being at least 35% more methylated (p < 0.05) in
newborn (1 week) as compared to adult hepatocytes. This slightly lower cutoff was
used to take into consideration the possible loss of methylation that takes place
immediately after birth, but prior to our first hepatocyte DNA sample (1 week). The
same process was performed for tissue-specific demethylation of other tissues (lung,
heart, and hippocampus). WGBS was analyzed in a similar manner to the RRBS
data. Two hundred base pair DMRs with a minimum coverage of 15 CpGs were
identified. In order to find hepatocyte-specific undermethylated tiles at the whole-
genome level, we compared our results to a published data set on other tissues
(GSE42836). Postnatal tiles were found using similar parameters to those of RRBS.
Genomic feature annotation of DMRs was carried out with annotatePeaks.pl
with the promoter defined as −1 kb to+ 100 bp of the TSS, intragenic regions
including coding exons, the 3′ and 5′ UTRs, introns, and an additional 1 kb beyond
the transcription termination sequence. Everything else is considered to be
intergenic.
The statistical significance of the original tissue-specific DMR set was calculated
using a permutation test: The p value was obtained by measuring the quantile of
the original DMR size. In each permutation we replaced the same number of
samples with random samples from other tissues. Since we had nine tissues and
each one of them contained on average six different samples, we could repeat this
process numerous times. In the case of hepatocytes, the original number of
hepatocyte-specific unmethylated regions was ~9000, and analysis of 10,000
permutations yielded at most five DMRs. The reason for this very low number is
that when comparing mixed tissues to other tissues with our very stringent
parameters, it yields almost no DMRs, demonstrating the purity of our DMRS. The
p value was calculated to be smaller than 10−4 since for 10,000 permutations
almost no DMRs were found. DMRs were also validated by the examination of
methylation status on new RRBS and WGBS samples that did not participate in the
original analysis. In addition, comparison using methylKit in R with similar cutoff
criteria detected 4790 DMRs, of which 93% overlapped with the 9291 DMRs
generated by our algorithm (p value <10−100 as determined by the χ2 test of
homogeneity).
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For RNA-Seq, ChIP-Seq and ATAC-Seq sequences were trimmed with cutadapt
v.1.15 and aligned with bowtie2 v.2.2.4. Duplicated sequences were removed with
samtools rmdup. RNA-Seq 50 bp single-end reads were obtained from HiSeq 2500
and analyzed by TopHat2 (Ref. 50). Differential expression was identified by
CuffDiff and Cufflink version 2.2.1 (Ref. 51) (p value ≤0.05). These data were
normalized by counting fragments per kilobase million units and dividing by the
average of all treatments. Our studies also allowed us to look at the overall effects of
preventing postnatal demethylation. RNA-Seq, for example, identified a total of
about 870 genes that are expressed at lower levels in the DKO as compared to WT
20-week hepatocytes and many of these (n~400) are significantly upregulated
postnatally. We also detected 790 genes that are actually upregulated in the
knockout as compared to WT. These changes may result from indirect effects
downstream of the primary methyl-dependent genes or from activities of the TET
proteins not related to DNA methylation52. Alternately, they may come about as a
compensation response to changes in physiology resulting from the DKO.
Expression in non-hepatocyte tissues was derived from published RNA-Seq data
(Brain—Adult: ENCFF001LBM, ENCFF001LBR, Newborn: ENCFF037JQC,
ENCFF447EXU, ENCFF002EYI, ENCFF002EYD; Lung—Adult: ENCFF001LDK,
ENCFF001LDL, Newborn: ENCFF333IFD, ENCFF542DBJ; Heart—Adult:
ENCFF001LCD, ENCFF001LCE, Newborn: ENCFF034XQS, ENCFF381RLD).
ChIP-Seq and 5hmDIP-Seq 50 bp single-end reads were obtained from HiSeq
2500 and analyzed by Homer (findPeaks, histone, or factor style) and heatmaps
were prepared by Deeptools (computeMatrix). ChIP-Seq distribution was
generated by Homer (annotatePeaks.pl). The Genome browser view was generated
by converting Bam files into using the bedGraphToBigWig tool and then uploaded
on the IGVtools (count). ChIP-Seq data were obtained from the publicly available
GEO database, including H3K4me1 and H3K27ac data from the liver, lung, heart,
and hippocampus collected from the ENCODE website (https://www.
encodeproject.org/), HNF4α (GSM1390711), RXRa (GSM864674), PPARα
(GSM864671), and DNaseI (GSM542592). Motif analysis was carried out by
HOMER (findMotifsGenome.pl). For ATAC-Seq 75 PE sequences were aligned
and duplicated as well as mitochondrial DNA was removed before peak calling by
homer.
Published liver Hi-C datasets (GSE65126) were aligned to the mouse genome
(mm9) using Bowtie. Aligned reads were analyzed using HOMER, filtering out
paired reads that map within 1 kb of each other that map to regions with at least 5×
higher than average sequencing coverage or that are not within 500 bp of a HindII
site. Interactions with a p value <0.01 and a modified z-score >1.5 were calculated
with the analyze Hi-C interactions tool in the HOMER package, using a
background model of 10 kb bins. Interactions between promoters and DMRs were
identified from this list using the HOMER annotateInteractions.pl tool. Genes that
show down-regulation in the Tet2/3 DKO were identified from the above list.
Data availability. The sequencing data have been deposited in the GEO under
accession number GSE85251. Accession codes for previously available datasets also
used here are listed in the data analysis section. The data that support the findings
of this study are available from the corresponding author upon reasonable request.
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